Portfolio company
LTB4 Sweden AB
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops leukotriene B4 based therapies to treat inflammatory conditions and infectious diseases, such as HIV, for patients with unmet medical needs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Transient Pharma AB
This company develops systemic peptide-based drugs for patients with inflammatory conditions, focusing on gastrointestinal disorders and acute infections.
Aqilion
This biotech company develops early-stage drug treatments for chronic inflammatory diseases to supply pharmaceutical and biotechnology partners with new clinical development projects.
LTZ Therapeutics
This biopharma company develops myeloid engager immunotherapies for patients with cancer and autoimmune diseases.
Resistentia Pharmaceuticals AB
This company develops immunotherapeutic products for patients suffering from allergic asthma and inflammatory disorders.
Apini Therapeutics
This biotechnology company develops small molecule compounds to treat chronic inflammatory diseases for healthcare providers and patients.
Veralox
This biotechnology company develops small-molecule therapeutics to treat inflammatory hematologic diseases and type 1 diabetes for patients with unmet medical needs.
Biolipox AB
This pharmaceutical company develops treatments for respiratory and inflammatory diseases including asthma and arthritis for patients and healthcare providers.
Oncopeptides AB
This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.